Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04513808 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Total Intravenous Anesthesia and Recurrence Free Survival

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Dec 2025 → Dec 2026
See other at-risk trials from The Cleveland Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 2025 to Dec 2026v7
  2. Re-verified, no change to tracked fieldsv6
  3. Enrollment target: 950 to 1614v5 Show 4 more changesShow less
    • Primary completion date: Dec 2024 to Dec 2025
    • Study completion date: Dec 2024 to Dec 2027
    • Secondary endpoints: 1 to 3
    • Site contact updated
  4. 2 versions Re-verified since Aug 26, 2021, no change to tracked fieldsv3-v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 2020 to Aug 15, 2020
    • Site details revised
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators propose to compare recurrence-free survival in patients having potentially curative (Stages 1-3) surgery for esophageal cancer who will be randomly assigned to propofol-based total intravenous anesthesia or sevoflurane-based balanced general anesthesia.
Trial Details
NCT Number NCT04513808
Lead Sponsor The Cleveland Clinic
Conditions
(from sponsor)		 Esophageal Cancer
Related terms Esophageal Neoplasms
Enrollment 1,614 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov